三星医疗(601567) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 reached CNY 3,436,248,747.55, representing a year-on-year increase of 23.21%[2] - The net profit attributable to shareholders for Q3 2024 was CNY 665,687,340.41, reflecting a growth of 7.43% compared to the same period last year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 670,134,894.17, up 30.03% year-on-year[2] - The basic earnings per share for Q3 2024 was CNY 0.47, an increase of 7.22% compared to the previous year[4] - Total operating revenue for the first three quarters of 2024 reached ¥10,433,714,281.29, a 25.2% increase from ¥8,337,759,691.76 in the same period of 2023[18] - Net profit for the first three quarters of 2024 was ¥1,822,779,409.65, representing a 21.6% increase compared to ¥1,498,941,843.85 in the previous year[19] - The net profit for the first three quarters of 2024 was CNY 547,352,517.89, down from CNY 1,927,763,538.12 in the previous year, representing a decline of 71.6%[27] Cash Flow and Liquidity - The net cash flow from operating activities for Q3 2024 was CNY 768,968,478.14, with a significant increase of 250.48% year-to-date[2] - The net cash flow from operating activities was CNY 1,029,211,957.25, significantly up from CNY 293,656,895.75 in the previous year, indicating a strong operational performance[21] - Cash and cash equivalents at the end of the period stood at CNY 2,187,484,508.27, up from CNY 1,465,879,580.62 at the end of 2023, showing a substantial increase in liquidity[22] - The company reported a net cash outflow from investing activities of CNY -640,932,385.96, compared to CNY -402,676,809.04 in the previous year, indicating increased investment efforts[22] - Total cash inflow from financing activities was CNY 991,114,278.70, down from CNY 1,804,400,689.20 in the same period last year, reflecting a decrease in financing activities[22] - The company’s cash flow from operating activities showed a significant change, reflecting the impact of reduced revenue and increased costs[27] Assets and Liabilities - The total assets at the end of the reporting period were CNY 21,308,685,788.88, showing a decrease of 0.95% from the end of the previous year[4] - The total liabilities decreased to ¥9,431,166,282.04 from ¥10,359,714,479.63, indicating a reduction of approximately 8.9%[17] - The total equity attributable to shareholders rose to ¥11,700,018,960.94, up from ¥11,005,533,096.56, reflecting a growth of 6.3%[17] - The company’s total assets as of September 30, 2024, included CNY 2,630,083,305.06 in other receivables, a significant increase from CNY 1,908,042,131.16 at the end of 2023[23] - The total liabilities rose to CNY 4,913,103,512.82, compared to CNY 3,581,006,272.71, marking an increase of 37.1%[26] Operational Highlights - The gross profit margin for the first three quarters of 2024 was 36.21%, an increase of 2.59 percentage points year-on-year[10] - The company reported a 26.54% year-on-year increase in revenue from the smart power distribution segment for the first three quarters of 2024[9] - The overseas capacity ratio increased to approximately 50%, with significant growth in overseas power distribution business following successful market entries in the Middle East, Europe, and America[9] - The company has a total of 15.62 billion RMB in hand orders, representing a year-on-year growth of 35.18%[13] - The company has a significant increase in overseas orders, with a year-on-year growth of 272.51% in overseas distribution orders[13] Research and Development - Research and development expenses increased to ¥413,019,007.29, a rise of 29.3% from ¥319,474,410.37 in the same period last year[18] - Research and development expenses for the first three quarters were CNY 101,240,517.46, an increase of 12.7% from CNY 90,325,485.92 in the same period last year[27] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 17,664[11] - The company has no pledged, marked, or frozen shares among its top shareholders[11]